Clofarabine European Study Confirms Efficacy in Pediatric Patients with Acute Lymphoblastic Leukemia; Study Update at American Society of Hematology.
Business Wire › December 13, 2005
Linked as:
Extract
Clofarabine European Study Confirms Efficacy in Pediatric Patients with Acute Lymphoblastic Leukemia; Study Update at American Society of Hematology.
ATLANTA -- Bioenvision (Nasdaq:BIVN) today provided preliminary data from the Company's Phase II sponsored study of clofarabine in pediatric patients with relapsed/refractory Acute Lymphoblastic Leukemia (ALL). The update was given to a meeting of study investi...
See the full content of this document
Sponsored links
